Comments on O. Reg. 201/96, Regulation 935 'Reducing Administrative Burden to Drug Manufacturers and Pharmacies'

Date de parution : 11/27/2019
Personne(s)-ressource(s) : Joan Weir

Input provided into the proposed regulatory changes identified on October 28, 2019. In 2018, insurers, through benefit plans provided by employers, accounted for over 35% of the spending on prescription drugs in Ontario.